BAX
41
3
UAL
34
-3
CFG
34
4
MET
60
2
GS
65
2
JNPR
56
2
VLO
33
-5
CHK
5
-7
EL
45
2
K
30
-2
GPC
35
-9
FLR
36
-3
AKAM
48
-11
AMG
44
-3
PM
52
-4
MCHP
52
3
IPG
42
-2
OMC
53
3
V
66
-4
PNW
49
4
BAX
41
3
UAL
34
-3
CFG
34
4
MET
60
2
GS
65
2
JNPR
56
2
VLO
33
-5
CHK
5
-7
EL
45
2
K
30
-2
GPC
35
-9
FLR
36
-3
AKAM
48
-11
AMG
44
-3
PM
52
-4
MCHP
52
3
IPG
42
-2
OMC
53
3
V
66
-4
PNW
49
4
Financhill
Back

SPDR® MSCI ACWI ex-US ETF Vs. Ultragenyx Pharmaceutical Industry Stock Comparison

Buy
59

CWI
SPDR® MSCI ACWI ex-US ETF

Last Price:
28.20
Seasonality Move:
0.43%
Sell
43

RARE
Ultragenyx Pharmaceutical

Last Price:
39.58
Seasonality Move:
3.65%
Buy
59
SPDR® MSCI ACWI ex-US ETF (CWI) is a Buy

Is SPDR® MSCI ACWI ex-US ETF a Buy, Sell or Hold?

  • The current SPDR® MSCI ACWI ex-US ETF [CWI] share price is $28.19. The Score for CWI is 59, which is 18% above its historic median score of 50, and infers lower risk than normal.
  • CWI is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Sell
43
Ultragenyx Pharmaceutical (RARE) is a Sell

Is Ultragenyx Pharmaceutical a Buy, Sell or Hold?

  • The current Ultragenyx Pharmaceutical [RARE] share price is $39.60. The Score for RARE is 43, which is 14% below its historic median score of 50, and infers higher risk than normal.
  • RARE is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

CWI Stock Price Chart

What is SPDR® MSCI ACWI ex-US ETF's stock price today?

  • The SPDR® MSCI ACWI ex-US ETF share price today is $28.19
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and CWI is experiencing slight buying pressure.

RARE Stock Price Chart

What is Ultragenyx Pharmaceutical's stock price today?

  • The Ultragenyx Pharmaceutical share price today is $39.60
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and RARE is experiencing buying pressure, which is a positive indicator for future bullish movement.

CWI Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.09 Sell
Relative Strength Index (14 RSI): 43.47 Sell
Chaikin Money Flow: 14510 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (28.33 - 29.03) Sell
Bollinger Bands (100): (27.35 - 28.71) Buy

RARE Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.73 Sell
Relative Strength Index (14 RSI): 45.77 Sell
Chaikin Money Flow: 722527 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (38.99 - 42.29) Sell
Bollinger Bands (100): (41.03 - 48.83) Sell

CWI Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 28.3 Sell
20-day SMA: 28.55 Sell
50-day SMA: 28.35 Sell
200-day SMA: 26.84 Buy
8-day EMA: 28.33 Sell
20-day EMA: 28.47 Sell
50-day EMA: 28.38 Sell
200-day EMA: 27.28 Buy

RARE Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 40.38 Sell
20-day SMA: 40.41 Sell
50-day SMA: 41.94 Sell
200-day SMA: 42.46 Sell
8-day EMA: 39.76 Sell
20-day EMA: 40.54 Sell
50-day EMA: 42.03 Sell
200-day EMA: 43.46 Sell

SPDR® MSCI ACWI ex-US ETF Earnings Growth & CWI Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.

Ultragenyx Pharmaceutical Earnings Growth & RARE Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.49 per share, an increase next quarter of $0.01 per share, an increase this year of $0.90 per share, and an increase next year of $1.07 per share.

SPDR® MSCI ACWI ex-US ETF Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Ultragenyx Pharmaceutical Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):